Literature DB >> 23381673

Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients.

Stefano Scaringi1, Carmela Di Martino, Daniela Zambonin, Marilena Fazi, Giuseppe Canonico, Francesca Leo, Ferdinando Ficari, Francesco Tonelli.   

Abstract

BACKGROUND: The relation between Crohn's colitis (CC) and colorectal cancer is still controversial. Several case reports and retrospective studies have shown that patients with Crohn's disease (CD) have a 6- to 20-fold higher risk to develop CRC than does the normal population. The extent of disease (extensive colitis), presence of anal fistula, age > 40 years, strictures, and length of disease >10 years may be important determinants for increasing risk. Despite this evidence, other population-based studies have shown no increased risk of colon or rectal cancer. The aim of this study was to investigate retrospectively factors that may predict the development of cancer.
METHODS: We searched the histopathologic database of the Digestive Surgery Unit at Careggi University Hospital for CC patients (January 1987 to September 2011) and identified 313 patients with CC who underwent surgery.
RESULTS: There are 11 (3.5 %) of adenocarcinomas. Multivariate analysis showed disease duration (p = 0.001), age at CD diagnosis (p = 0.002), distal localization (p = 0.045), and penetrating disease (p = 0.041) to be risk factors. Multivariate analysis showed that 40 patients who had undergone previous immunosuppressive therapy had a significant risk of developing CRC (p = 0.026).
CONCLUSIONS: Crohn's colitis patients who require surgery are at higher risk for developing CRC, particularly those whose disease duration is >10 years, have distal localization, age at diagnosis was <40 years, and have penetrating disease. Previous immunosuppressive therapy should be better investigated. We recommend surgery for any patient presenting with colonic strictures.

Entities:  

Mesh:

Year:  2013        PMID: 23381673     DOI: 10.1007/s00268-013-1922-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  37 in total

1.  Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight.

Authors:  R Kiesslich; M F Neurath
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

2.  The development of carcinoma of the large intestine in ulcerative colitis.

Authors:  I M DAWSON; J PRYSE-DAVIES
Journal:  Br J Surg       Date:  1959-09       Impact factor: 6.939

3.  Feasibility and accuracy of confocal endomicroscopy in comparison with narrow-band imaging and chromoendoscopy for the differentiation of colorectal lesions.

Authors:  T Kuiper; F J C van den Broek; S van Eeden; P Fockens; E Dekker
Journal:  Am J Gastroenterol       Date:  2012-03-20       Impact factor: 10.864

4.  Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.

Authors:  Ann Corken Mackey; Lanh Green; Li-Ching Liang; Patricia Dinndorf; Mark Avigan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-02       Impact factor: 2.839

5.  Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.

Authors:  Justin A Maykel; Gonzalo Hagerman; Anders F Mellgren; Shelby Y Li; Karim Alavi; Nancy N Baxter; Robert D Madoff
Journal:  Dis Colon Rectum       Date:  2006-07       Impact factor: 4.585

6.  Hepatosplenic T cell lymphoma in inflammatory bowel disease.

Authors:  Matthew Shale; Ed Kanfer; Remo Panaccione; Subrata Ghosh
Journal:  Gut       Date:  2008-07-30       Impact factor: 23.059

7.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

8.  Intestinal cancer in patients with Crohn's disease. A population study in central Israel.

Authors:  Z Fireman; A Grossman; P Lilos; D Hacohen; S Bar Meir; P Rozen; T Gilat
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

9.  Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis.

Authors:  Ralf Kiesslich; Martin Goetz; Katharina Lammersdorf; Constantin Schneider; Juergen Burg; Manfred Stolte; Michael Vieth; Bernhard Nafe; Peter R Galle; Markus F Neurath
Journal:  Gastroenterology       Date:  2007-01-31       Impact factor: 22.682

10.  Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years.

Authors:  Z Maratka; J Nedbal; J Kociánová; J Havelka; J Kudrmann; J Hendl
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

View more
  9 in total

Review 1.  Colorectal cancer in inflammatory bowel disease: review of the evidence.

Authors:  D S Keller; A Windsor; R Cohen; M Chand
Journal:  Tech Coloproctol       Date:  2019-01-30       Impact factor: 3.781

Review 2.  Epithelial-mesenchymal transition in Crohn's disease.

Authors:  H Jiang; J Shen; Z Ran
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

Review 3.  [Operative therapy of chronic inflammatory bowel diseases. Indications and importance].

Authors:  C-T Germer; C Isbert
Journal:  Internist (Berl)       Date:  2014-08       Impact factor: 0.743

4.  Establishment and characterization of HROC69 - a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft.

Authors:  Florian Kuehn; Christina S Mullins; Mathias Krohn; Christine Harnack; Robert Ramer; Oliver H Krämer; Ernst Klar; Maja Huehns; Michael Linnebacher
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379

Review 5.  Indications and surgical options for small bowel, large bowel and perianal Crohn's disease.

Authors:  James Wt Toh; Peter Stewart; Matthew Jfx Rickard; Rupert Leong; Nelson Wang; Christopher J Young
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

Review 6.  Colonic Crohn's disease - decision is more important than incision: A surgical dilemma.

Authors:  Maria Michela Chiarello; Maria Cariati; Giuseppe Brisinda
Journal:  World J Gastrointest Surg       Date:  2021-01-27

7.  Clinicopathological Characteristics and Surgical Outcomes of Crohn Disease-Associated Colorectal Malignancy.

Authors:  Yoo Na Lee; Jong Lyul Lee; Chang Sik Yu; Jong Beom Kim; Seok-Byung Lim; In Ja Park; Young Sik Yoon; Chan Wook Kim; Suk-Kyun Yang; Byong Duk Ye; Sang Hyoung Park; Jin Cheon Kim
Journal:  Ann Coloproctol       Date:  2021-04-30

Review 8.  Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis.

Authors:  Paulina Núñez F; Noa Krugliak Cleveland; Rodrigo Quera; David T Rubin
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

9.  Clinicopathological characteristics of cancer associated with Crohn's disease.

Authors:  Hirofumi Sasaki; Hiroki Ikeuchi; Toshihiro Bando; Kei Hirose; Akihiro Hirata; Teruhiro Chohno; Yuki Horio; Naohiro Tomita; Seiichi Hirota; Yoshihiro Ide; Yasuaki Tsuchida; Motoi Uchino
Journal:  Surg Today       Date:  2016-04-19       Impact factor: 2.549

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.